Stay updated on Reirradiation With Pembrolizumab in Head-and-Neck Clinical Trial

Sign up to get notified when there's something new on the Reirradiation With Pembrolizumab in Head-and-Neck Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Reirradiation With Pembrolizumab in Head-and-Neck Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-04-30T18:02:39.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page has undergone significant updates, including the removal of detailed treatment protocols for a clinical trial involving pembrolizumab and the addition of new collaborators and a revision number. Notably, the core content regarding the trial's eligibility criteria and treatment regimen has been deleted.
    Difference
    22%
    Check dated 2025-04-16T12:43:52.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to March 6, 2025.
    Difference
    0.2%
    Check dated 2025-04-09T05:40:22.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.1%
    Check dated 2025-04-01T22:45:54.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    The webpage has been updated to include new results and metrics related to patient outcomes, specifically detailing the Quality of Life assessments using EORTC QLQ-C30 and EORTC QLQ-H&N35 questionnaires, as well as updated reporting dates for results. Notably, previous metrics such as Overall Response Rate and Clinical Benefit Rate have been removed.
    Difference
    58%
    Check dated 2025-03-11T04:07:22.000Z thumbnail image
  8. Check
    73 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1%
    Check dated 2025-02-24T20:24:53.000Z thumbnail image

Stay in the know with updates to Reirradiation With Pembrolizumab in Head-and-Neck Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Reirradiation With Pembrolizumab in Head-and-Neck Clinical Trial page.